Fresh Tracks Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.frtx.com
A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis
Phase 1
Terminated
- Conditions
- Atopic Dermatitis Eczema
- Interventions
- Drug: FRTX-02 CapsuleDrug: Placebo
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Fresh Tracks Therapeutics, Inc.
- Target Recruit Count
- 89
- Registration Number
- NCT05382819
- Locations
- 🇨🇦
Syneos Health Quebec, Montréal, Quebec, Canada
Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis
Phase 1
Completed
- Conditions
- Contact Dermatitis
- Interventions
- First Posted Date
- 2017-03-24
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- Fresh Tracks Therapeutics, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT03089775
- Locations
- 🇨🇦
Innovaderm Research Inc., Montreal, Quebec, Canada
A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects
- First Posted Date
- 2015-10-29
- Last Posted Date
- 2023-01-19
- Lead Sponsor
- Fresh Tracks Therapeutics, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02590289
- Locations
- 🇺🇸
Celerion Inc., Lincoln, Nebraska, United States
© Copyright 2025. All Rights Reserved by MedPath